These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Characteristics of the course of erysipelatous inflammation in servicemen]. Vitenchuk SZ Voen Med Zh; 1980 Mar; (3):65-7. PubMed ID: 7368612 [No Abstract] [Full Text] [Related]
3. [Complex treatment of erysipelas in a surgical clinic]. Iusupov IA; Iafarov RM Vestn Khir Im I I Grek; 1986 Jun; 136(6):75-8. PubMed ID: 3750718 [TBL] [Abstract][Full Text] [Related]
5. [Erysipelatous inflammation]. Rychnev VE; Frolov VM Med Sestra; 1983 Feb; 42(2):14-7. PubMed ID: 6551629 [No Abstract] [Full Text] [Related]
6. [Clinical aspects and diagnosis of erysipelas in adults]. Postovit VA Voen Med Zh; 1983 Dec; (12):41-3. PubMed ID: 6670188 [No Abstract] [Full Text] [Related]
7. [Erysipelatous inflammation of the breast]. Khomenko NI; Shapovalov IM; Taran VM; Alekseĭchuk IF; Vul'man IA Klin Khir (1962); 1979 Jan; (1):65-6. PubMed ID: 571491 [No Abstract] [Full Text] [Related]
8. [Clinical aspects and treatment of erysipelas]. Tarasov VI; Salmanova MA Voen Med Zh; 1983 Aug; (8):67-8. PubMed ID: 6636586 [No Abstract] [Full Text] [Related]
9. [The application wound sorption in complex treatment of destructive forms of erysipelas inflammation]. Rybachkov VV; Potapov PP; Sal'nikov EV; Kabanov EN Vestn Khir Im I I Grek; 2003; 162(5):82-4. PubMed ID: 14768113 [TBL] [Abstract][Full Text] [Related]
11. [The effect of cryotherapy on the erysipelatous process in experimental and clinical conditions]. APAKIDZE VK Klin Med (Mosk); 1959 Aug; 37():113-5. PubMed ID: 13793929 [No Abstract] [Full Text] [Related]
12. [Malonaldehyde and tumor necrosis factor-alpha as indicators of intoxication syndrome in erysipelatous inflammation]. Marzhokhova MIu; Afashagova MM; Marzhokhova AR Klin Lab Diagn; 2011 May; (5):20-2. PubMed ID: 21789799 [TBL] [Abstract][Full Text] [Related]
13. [Characteristics of clinical course and therapeutic tactics in erysipelatous inflammation of the breast]. Nechiporuk VM; Ochered'ko NA; Ryzhanovskaia VM Klin Khir (1962); 1976 Jan; (1):80-2. PubMed ID: 987499 [No Abstract] [Full Text] [Related]
14. [The efficacy of the ultraviolet irradiation of the blood in the combined treatment of erysipelatous inflammation]. Potashov LV; Reshetov AV; Tone RV; Vismont VG Vestn Khir Im I I Grek; 1992; 149(7-8):84-8. PubMed ID: 1341376 [TBL] [Abstract][Full Text] [Related]
15. [Use of ultraviolet irradiation of autologous blood in the combined treatment of erysipelatous inflammation]. Potashov LV; Cheminava RV; Reshetov AV Klin Khir (1962); 1987; (3):39-41. PubMed ID: 3573620 [No Abstract] [Full Text] [Related]
17. [Characteristics of the clinical course of erysipelas]. Suleĭmenova ZI; Turkpenbaeva GZh; Tsoĭ IG; Turkpenbaeva AZh Klin Med (Mosk); 1985 Jan; 63(1):125-8. PubMed ID: 3990177 [No Abstract] [Full Text] [Related]
18. [Erysipelas and lymphedema]. Herpertz U Fortschr Med; 1998 Apr; 116(12):36-40. PubMed ID: 9622973 [TBL] [Abstract][Full Text] [Related]
19. [Zoster and erysipelas. We family physicians can treat them very well, too]. Baum E MMW Fortschr Med; 2003 Feb; 145(8):16. PubMed ID: 12661436 [No Abstract] [Full Text] [Related]
20. [What data is needed today to deal with erysipelas?]. Hansmann Y Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):419-28. PubMed ID: 11319374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]